CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale SVP, Chief Medical Officer sold 2,555 shares at $4.70 ($12,006)
- 4 Open-market sale Sr. VP, Drug Development sold 6,844 shares at $4.70 ($32,187)
- 4 Open-market sale VP, Fin. and Admin., CFO sold 4,397 shares at $4.70 ($20,662)
- CT ORDER Other Confidential Order
- 10-K Report Annual Report
- 8-K Event Executive or director change
- 5 Insider Annual Insider Trading Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement
- 8-K Event Other events
- 4 Open-market buy Director bought 1,136,363 shares at $4.40 ($4,999,997)
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
Page 47 of 62 · 1,224 filings